GeneGo plans to use Entelos’ DrugMatrix gene expression data to further its Functional Descriptor predictive toxicology models. “Access to a comprehensive, pharmacologically diverse, and fully annotated compendium of gene expression data is critical to developing high-performance predictive models,” points out Richard Brennan, director of toxicology at GeneGo.
“DrugMatrix is the largest toxicogenomic database available and will allow us to apply the lessons we have learned from our participation in the Microarray Quality Control Consortium to expand our collection of biological pathway-based classifiers with toxicity models for a wide variety of adverse drug effects in key target tissues.”
